Eukaryotic translation initiator protein 1A isoform, CCS-3, enhances the transcriptional repression of p21CIP1 by proto-oncogene FBI-1 (Pokemon/ZBTB7A)

Cellular Physiology and Biochemistry

Volumn 23, Issue 4-6, 2009, Pages 359-370

  Choi, Won Il ^a   Kim, Youngsoo ^b   Kim, Yuri ^a   Yu, Mi Young ^a   Park, Jungeun ^b   Lee, Choong Eun ^c   Jeon, Bu Nam ^a   Koh, Dong In ^a   Hur, Man Wook ^a,d  

^a Yonsei University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

CCS 3; Co repressors; EEF1A; FBI 1; P21; Pokemon; POZ domain; Repression; Transcription

Indexed keywords

CERVICAL CANCER SUPPRESSOR 3; COREPRESSOR BCOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; ELONGATION FACTOR 1ALPHA; EUKARYOTIC TRANSLATION ELONGATION FACTOR 1A; PROTEIN FBI 1; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE ARREST; CELL PROLIFERATION; DNA BINDING; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR INTERACTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE; ZINC FINGER MOTIF;

EUKARYOTA;

EID: 66749116628     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000218182     Document Type: Article

References (42)

1. Bardwell VJ, Treisman R: The POZ domain: a conserved protein-protein interaction motif. Genes Dev 1994;8:1664-1677.
2. Kelly KF, Daniel JM: POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol 2006;16:578-587.
3. Pessler F, Pendergrast PS, Hernandez N: Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol 1997;17:3786-3798.
4. Lee DK, Suh D, Edenberg HJ, Hur MW: POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1. J Biol Chem 2002;277:26761-26768.
5. Morrison DJ, Pendergrast PS, Stavropoulos P, Colmenares SU, Kobayashi R, Hernandez N: FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res 1999;27:1251-1262.
6. Pendergrast PS, Wang C, Hernandez N, Huang S: FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles. Mol Biol Cell 2002;13:915-929.
7. Lee DK, Kang JE, Park HJ, Kim MH, Yim TH, Kim JM, Heo MK, Kim KY, Kwon H J, Hur MW: FBI-1 activates transcription of NF-kB responsive E-selectin gene by nuclear localization of p65 subunit of NF-B. J Biol Chem 2005;280:27783-27791.
8. Laudes M, Christodoulides C, Sewter C, Rochford JJ, Considine RV, Sethi JK, Vidal-Puig A, O'Rahilly S: Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis. J Biol Chem 2004;279:11711-11718.
9. Kukita A, Kukita T, Ouchida M, Maeda H, Yatsuki H, Kohashi O: Osteoclast-Derived Zinc Finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 1999;94:1987-1997.
10. Davies JM, Hawe N, Kabarowski J, Huang QH, Zhu J, Brand NJ, Leprince D, Dhordain P, Cook M, Morriss-Kay G., Zelent A: Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 1999;18:365-375.
11. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, Teruya-Feldstein J, Pandolfi PP: Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 2005;433:278-285.
12. Maeda T, Merghoub T, Hobbs RM, Dong L, Maeda M, Zakrzewski J, van den Brink MR, Zelent A, Shigematsu H, Akashi K, Teruya-Feldstein J, Cattoretti G. Pandolfi PP: Regulation of B versus T lymphoid lineage fate decision by the protooncogene LRF. Science 2007;316:860-866.
13. Merrick WC, Nyborg J: The protein biosynthesis elongation cycle; in Sonenberg N, Hershey JWB, Mathews MB (eds): Translational Control of Gene Expression. Cold Spring Harbor, N.Y., Cold Spring Harbor Laboratory Press, 2000, pp 89-125.
14. Lamberti A, Caraglia M, Longo O, Marra M, Abbruzzese A, Arcari P: The translation elongation factor 1A in tumorigenesis, signal transduction and apoptosis: review article. Amino Acids 2004;26:443-448.
15. Sonenberg N: Translation factors as effectors of cell growth and tumorigenesis. Curr Opin Cell Biol 1993;5:955-960.
16. Al-Maghrebi M, Anim JT, Olalu AA: Up-regulation of eukaryotic elongation factor-1 subunits in breast carcinoma. Anticancer Res 2005;25(3c):2573-2577.
17. Kato MV, Sato H, Nagayoshi M, Ikawa Y: Upregulation of the elongation factor-1alpha gene by p53 in association with death of an erythroleukemic cell line. Blood 1997;90:1373-1378.
18. Dapas B, Tell G, Scaloni A, Pines A, Ferrara L, Quadrifoglio F, Scaggiante B: Identification of different isoforms of eEF1A in the nuclear fraction of human T-lymphoblastic cancer cell line specifically binding to aptameric cytotoxic GT oligomers. Eur J Biochem 2003;270:3251-3262.
19. Krieg PA, Varnum SM, Wormington WM, Melton DA: The mRNA encoding elongation factor-1 (eEF-1) is a major transcript at the midblastula transition in Xenopus. Dev Biol 1989;133:93-100.
20. Shepherd JCW, Walldorf U, Hug P, Gehring WJ: Fruit flies with additional expression of the elongation factor eEF-1 live longer. Proc Natl Acad Sci USA 1989;86:7520-7521.
21. Tatsuka M, Mitsui H, Wada M, Nagata A Nojima H, Okayama H: Elongation factor-1 gene determines susceptibility to transformation. Nature 1992;359:333-336.
22. Gopalkrishnan RV, Su ZZ, Goldstein NI, Fisher PB: Translational infidelity and human cancer: role of the PTI-1 oncogene. Int J Biochem Cell Biol 1999;31:151-162.
23. Su Z, Goldstein NI, Fisher PB: Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes. Proc Natl Acad Sci USA 1998;95:1764-1769.
24. Edmonds BT, Wyckoff J, Yeung YG, Wang Y, Stanley ER, Jones J, Segall J, Condeelis J: Elongation factor-1 alpha is an overexpressed actin binding protein in a metastatic rat mammary adenocarcinoma. J Cell Sci 1996;109:27052714.
25. Bohnsack MT, Regener K, Schwappach B, Saffrich R, Paraskeva E, Hartmann E, Görlich D: Exp5 exports eEF1A via tRNA from nuclei and synergizes with other transport pathways to confine translation to the cytoplasm. EMBO J 2002;21:6205-6215.
26. Gangwani L, Mikrut M, Galcheva-Gargova Z, Davis RJ: Interaction of ZPR1 with translation elongation factor-1 alpha in proliferating cells. J Cell Biol 1998;143: 1471-1484.
27. Colling DA, Wastenays GO, Miyazaki M, Williamson RE: Elongation factor 1 is a component of the subcortical actin bundles of characean algae. Cell Biol Int. 1994;18:1019-1024.
28. Janssen GMC, Van Damme HTF, Kriek J, Amons R, Moller W: The subunit structure of elongation factor 1 from Artemia salina; why two -chains in this complex. J Biol Chem 1994;269:1-8.
29. Barbarese E, Koppel DE, Deutscher MP, Smith CL, Ainger K, Morgan F, Carson JH: Protein translation components are colocalized in granules in oligodendrocytes. J. Cell Sci 1995;108:2781-2790.
30. Billaut-Mulot O, Fernandez-Gomez R, Loyens M, Ouaissi A: Trypanosoma cruzi elongation factor-1: nuclear localization in parasites undergoing apoptosis. Gene 1996;174:19-26.
31. Sanders J, Brandsma M, Janssen GMC, Dijk J, Moller W: Immunofluorescence studies of human fibroblasts demonstrate the presence of the complex of elongation factor-1 in the endoplasmic reticulum. J Cell Sci 1996;109:1113-1117.
32. Blackwell JL, Brinton MA: Translation elongation factor-1 alpha interacts with 3' stem-loop region of West Nile virus genomic RNA. J Virol 1997;71:6433-6444.
33. Blumenthal T, Carmichael GG: RNA replication: function and structure of Q-replicase. Ann Rev Biochem 1979;48:528-548.
34. Das T, Mathur M, Gupta AK, Janssen GMC, Banerjee AK: RNA polymerase of vesicular stomatitis virus specifically associates with translation elongation factor-1 for its activity. Proc Natl Acad Sci USA 1998;95:1449-1454.
35. Rho SB, Park YG, Park K, Lee SH, Lee JH: novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis. FEBS Lett 2006;580:4073-4080.
36. Toledo F, Wahl GM: Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006;6: 909-923.
37. Choi WI, Jeon BN, Yun CO, Kim PH, Kim SE, Choi KY, Kim SH, and Hur MW: Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1. J Biol Chem 2009; in press.
38. Lee JA, Suh DC, Kang JE, Kim MH, Park H, Lee MN, Kim JM, Jeon BN, Roh HE, Yu MY, Choi KY, Kim KY, Hur MW: Transcriptional activity of Sp1 is regulated by molecular interactions between the zinc finger DNA binding domain and the inhibitory domain with corepressors, and this interaction is modulated by MEK. J Biol Chem 2005;280:28061-28071.
39. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983;11:1475-1489.
40. Jeon BN, Yoo JY, Choi WI, Lee CE, Yoon HG, Hur MW: Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of corepressors. J Biol Chem 2008;283:33199-33210.
41. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817-825.
42. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-1174.